Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07106996

Mechanism of Red Yeast Rice Regulating Intestinal Indole Metabolism Pathway to Improve Chronic Inflammation in Polycystic Ovary Syndrome

Status
Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Sichuan Provincial People's Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to elucidate the effects of red yeast rice on the improvement of symptoms in patients with polycystic ovary syndrome(PCOS), and to analyze the dose-response relationship between intestinal microbiota and its metabolite, hydroxyindole, and clinical indicators of PCOS. The main questions it aims to answer are: How effective is red yeast rice in treating PCOS? Does the indole metabolic pathway of gut microbiota play a crucial role in the improvement of PCOS symptoms by red yeast rice? Participants will take 6 grams of red yeast rice daily for 6 months, and records will be kept of their PCOS clinical symptoms and indicators before the intervention, at the 3rd month post-intervention, and at the 6th month post-intervention. Additionally, biological samples from feces and serum will be collected at these time points.

Conditions

Interventions

TypeNameDescription
DRUGred yeast rice,RYRParticipants will take 6 grams of red yeast rice daily for 6 months.

Timeline

Start date
2025-07-28
Primary completion
2026-06-01
Completion
2026-08-01
First posted
2025-08-06
Last updated
2025-08-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07106996. Inclusion in this directory is not an endorsement.